Priority Considerations for Medicinal Cannabis-Related Research

Author:

Bonn-Miller Marcel O.1,Pollack Charles V.2,Casarett David3,Dart Richard4,ElSohly Mahmoud5,Good Larry6,Guzmán Manuel7,Hanuš Lumír8,Hill Kevin P.9,Huestis Marilyn A.10,Marsh Eric11,Sisley Susan12,Skinner Nancy13,Spahr Judith14,Vandrey Ryan15,Viscusi Eugene10,Ware Mark A.16,Abrams Donald17

Affiliation:

1. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

2. Department of Emergency Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.

3. Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

4. Rocky Mountain Drug and Poison Control Center, Denver, Colorado.

5. National Center for Natural Products Research, School of Pharmacy, University of Mississippi, Oxford, Mississippi.

6. Department of Medicine, State University of New York at Stony Brook, Stony Brook, New York.

7. Department of Biochemistry and Molecular Biology, Complutense University of Madrid, Madrid, Spain.

8. Department of Medicinal and Natural Products, Institute for Drug Research, The Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.

9. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

10. Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania.

11. Departments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

12. Colorado State University-Pueblo, Pueblo, Colorado.

13. University of Southern Indiana, Evansville, Indiana.

14. Lewes, Delaware.

15. Behavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland.

16. Department of Family Medicine, McGill University, Montreal, Quebec, Canada.

17. UCSF Osher Center for Integrative Medicine, University of California-San Francisco, San Francisco, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3